The genetics of inflammatory bowel disease

Gastroenterology Clinics of North America

Volumn 31, Issue 1, 2002, Pages 63-76

  Duerr, Richard H ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^c 5724 Biomedical Science Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROHN DISEASE; ENTERITIS; ENVIRONMENTAL FACTOR; FUTUROLOGY; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; GENETICS; HLA SYSTEM; HUMAN; IMMUNOREGULATION; INFLAMMATION; MOLECULAR INTERACTION; NOD2 GENE; PATHOGENESIS; PENETRANCE; REVIEW; RISK FACTOR; ULCERATIVE COLITIS; IMMUNOLOGY;

CARD15 PROTEIN, HUMAN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; SIGNAL PEPTIDE;

CARRIER PROTEINS; CROHN DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NOD2 SIGNALING ADAPTOR PROTEIN;

EID: 0035986122     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(01)00005-X     Document Type: Article

References (110)

1. Fine mapping of regions linked to Crohn's disease on chromosomes 12 and 16
2. Association of HLA-DR15, p-ANCA and IL-I receptor antagonist allele 2 with ulcerative colitis
3. Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus - A GISC study
4. Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis
5. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis
6. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease
7. Genetic markers in clinically well defined patients with ulcerative colitis (UC)
8. Crohn's disease in a defined population: An epidemiological study of incidence, prevalence, mortality, and secular trends in the city of Malmö, Sweden
9. American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12
10. A meta-analysis of the role of smoking in inflammatory bowel disease
11. The epidemiology of idiopathic inflammatory bowel disease
12. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians
13. HLA antigens in ulcerative colitis: A study in the Sicilian population
14. Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16
15. American and Australian families with IBD demonstrate significant evidence for linkage at chromosome 1p35-6, IBD3
16. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: Evidence for epistasis between 1p and IBD1
17. Effects of misspecifying genetic parameters in lod score analysis
18. Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16
19. GENEHUNTER 2.0 - A complete linkage analysis system
20. Association of HLA class II genes with susceptibility to Crohn's disease
21. Nonparametric simulation-based statistics for detecting linkage in general pedigrees
22. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL
23. HLA antigens in ulcerative colitis and Crohn's disease in Israel
24. Associations between HLA-DR alleles and subsets of ulcerative colitis defined by extent of colitis
25. Linkage and association between inflammatory bowel disease and a locus on chromosome 12
26. Transmission/disequilibrium test analysis of a genome scan dataset detects a novel, significant inflammatory bowel disease linkage to chromosome 3p
27. The IBD4 locus shows linkage heterogeneity between Crohn's disease and ulcerative colitis
28. High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12
29. Association between ulcerative colitis and a polymorphism in intron 2 of the interleukin-1 receptor antagonist gene
30. Experimental models to study molecular mechanisms underlying intestinal inflammation
31. HLA DR2 is a susceptibility marker for UC in British patients irrespective of ANCA positivity
32. Inflammatory bowel disease: Etiology and pathogenesis
33. Immunological studies in Crohn's disease: I. Association with HLA systems in the Japanese
34. HLA-DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression
35. A subgroup of ulcerative colitis (UC) defined with genetic (HLA-DR) and immunological (pANCA) markers
36. Inflammatory bowel disease: No association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms
37. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort
38. Linkage of inflammatory bowel disease to human chromosome 6p
39. Affected-sib-pair interval mapping and exclusion for complex genetic traits: Sampling considerations
40. Crohn's disease in Stockholm county, 1955-1974: A study of epidemiology, results of surgical treatment and long term prognosis
41. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases
42. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease
43. HLA antigens in inflammatory bowel disease
44. Increased intestinal permeability in patients with Crohn's disease and their relatives: A possible etiologic factor
45. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
46. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
47. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16
48. Human nod1 confers responsiveness to bacterial lipopolysaccharides
49. Transmission disequilibrium testing confirms the association of the TNFα 1031C allele with Crohn's disease
50. Family occurrences of ulcerative colitis, regional enteritis, and ileocolitis
51. HLA-DR, DQ and T cell antigen receptor constant beta genes in Japanese patients with ulcerative colitis
52. Crohn's disease in the Japanese is associated with the HLA-DRw53
53. Allele-sharing models: LOD scores and accurate linkage tests
54. From Crohn to Crohn's disease: 1979: An epidemiologic study in New York City
55. Parametric and nonparametric linkage analysis: A unified multipoint approach
56. The genetics of Crohn disease: Complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives
57. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
58. Linkage methods for identifying genetic risk factors
59. Cytokine gene polymorphisms in inflammatory bowel disease
60. A genome-wide search identifies potential new susceptibility loci for Crohn's disease
61. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
62. Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice
63. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist
64. An HLA study on 149 Japanese patients with Crohn's disease
65. Is small intestinal permeability really increased in relatives of patients with Crohn's disease?
66. An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore: I. Hospital incidence and prevalence, 1960 to 1963
67. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease
68. Evidence for a major additive gene in ulcerative colitis
69. HLA antigens in ulcerative colitis
70. HLA-linked susceptibility and resistance genes in Crohn's disease
71. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene
72. Association of an HLA-DQB-1 genotype with Crohn's disease in children
73. Incidence of Crohn's disease at Groote Schuur Hospital during 1970-1974
74. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: Rarity of diagnosis and clinical features
75. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
76. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappa B
77. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis
78. Concordance of inflammatory bowel disease among Danish twins: Results of a nationwide study
79. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis
80. Familial occurrence of inflammatory bowel disease
81. Genetic linkage analysis under uncertain disease definition
82. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies
83. The IBD2 locus shows linkage heterogeneity between ulcerative colitis and Crohn disease
84. Susceptibility loci in inflammatory bowel disease
85. Fine mapping the IBD linkage on chromosome 3
86. Familial aggregation in Crohn's disease: Increased age-adjusted risk and concordance in clinical characteristics
87. Effect of religious affiliation and education status on the prevalence of inflammatory bowel disease in northern Alberta
88. Prevalence and family risk of ulcerative colitis and Crohn's disease: An epidemiological study among Europeans and south Asians in Leicestershire
89. Gene and haplotype frequencies of HLA antigens in 269 patients with Crohn's disease
90. HLA class II gene frequencies in Crohn's disease: A population based analysis in Germany
91. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci
92. Genetic markers may predict disease behavior in patients with ulcerative colitis
93. The influence of normal microbial flora on the development of chronic mucosal inflammation
94. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
95. The prevalence of inflammatory bowel disease in relatives of patient's with Crohn's disease
96. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease
97. Evidence for linkage between Crohn's disease (CD) and a locus near the major histocompatibility complex (MHC) on chromosome 6 in a Canadian inflammatory bowel disease (IBD) population
98. HLA antigens in inflammatory bowel disease
99. Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis
100. Genetics versus environment in inflammatory bowel disease: Results of a British twin study
101. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
102. Distinct associations of HLA class II genes with inflammatory bowel disease
103. HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations
104. HLA antigens and ulcerative colitis in Japan
105. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins: A study of heritability and the influence of smoking
106. Replication of linkage on 14q11-12 in inflammatory bowel disease (IBD)
107. Familial empiric risks for inflammatory bowel disease: Differences between Jews and non-Jews
108. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses
109. Genetic aspects of idiopathic inflammatory bowel disease